The design and synthesis of novel, potent and orally bioavailable N-aryl piperazine-1-carboxamide CCR2 antagonists with very high hERG selectivity
Keywords: CAOVTUXLXXVRSK-AIPQICINSA-N; CCR2 antagonists; Chemokine receptor; hERG;